Diagnostica hypothetica: Cancri Diagnosis et Patientia Management 2021
48 Videos + 2 PDFs, Course Size = 13.30 GBHabebis TRACTUS VIA AEVUM DOWNLOAD LINK (FAST SPEED) post solutionem
In Diagnostica hypothetica: Cancer Diagnosis et Patientia Managementperiti in agro recensentes notiones currentes et in technicae artis hodiernae, in convenientem usum pertentationum hypotheticarum pro diversis generibus tumoris ad informandam diagnosim, prognosin aut curationem utentes argumentis indiciis substructis.
Praelectiones in hoc online CME cursus communes diagnostic foveas illustrant, addito umbilico de variantibus interpretatione et multiplicitate exosculationis pro probationibus hypotheticis. Medicam educationem continuat quae te adiuvabit:
- Explicare oportet TEXTUS-pertractatio protocols
- Aestimare artes cytogeneticas et hypotheticas, inter posteros pertentationes sequentes
- Agnosce sumptus-efficaces, sensitivos aditus ad studia hypothetica, inter cellam liberam DNA probationem
- Processum determinare clinicae interpretationis variationis geneticae
- Duis gratuita et potentia vectigalia pro programmatibus diagnosticis hypotheticis
- Animadverte essentiales et emergentes biomarkes in adultis et solidis et liquidis tumoribus communibus pediatricis
Learning Objectives
Hac activitate expleta, participes melius valebunt;
- Explicare oportet textus-pertractatio protocolla ut facilior hypothetica probatio
- Aestimare artes cytogeneticas et hypotheticas comprehendens varias species generationis sequentis consequentis pertentationes
- Agnosce sumptus-efficaces et sensitivos aditus ad studia hypothetica in diagnostica cancer, inter exsequendam cellulam liberam DNA probationem.
- Processum determinare clinicae variationis geneticae interpretationis
- Expendere sumptus et potential fontes vectigalium pro programmatibus diagnosticis hypotheticis
- Considerate biomarkers essentiales et emergentes hypotheticas in adultis communibus et solidis et liquidis tumoribus pediatricis
Target Audience
Hoc cursum adiuvabunt pathologi, oncologi, et baculum PhD exercitatum in laboratoriis diagnosticis hypotheticis vel in industria pharmaceutica, necnon trainees in Oncologia et Pathologia.
Et Theodotionis Topics:
Introductio ad Diagnostics hypotheticas - Fei Dong, MD
Specimen Tractantem de Successu Moleculari - Lynette Sholl M., MD
Introductio ad Cytogeneticam Techniques - Azra Ligon, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Dong, Sholl et Ligon
Introductio ad Generationem Sequencing - Laura MacConaill, PhD
Introductio ad Pipelines Bioinformatic pro NGS - Ryan J. Schmidt, MD, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. MacConaill et Schmidt
Introductio ad Liquid Biopsy (Cell Free DNA Sequencing) - Technical Topics Long Phi Le, MD, PhD
Introductio ad Liquid Biopsy (Cell Free DNA Sequencing) - Volume Applications - Giulia Siravegna, PhD
Tumor Mutatio Onus et Microsatellite Instabilitas Testis - Jonathan Nowak, MD, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Le et Nowak
Vivere Provectus Workshop: Informatics - Long Phi Le, MD, PhD
Diagnostics hypotheticae pro Pectus Cancer - Debbora Dillon, MD
Diagnostics hypotheticae de Tumoribus Gynecologicis - Lauren Ritterhouse, MD, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Dillon et Ritterhouse
Diagnostica hypothetica Melanoma - Ryan J. Sullivan, MD
Diagnostics hypotheticae de Tumoribus Pediatricis et Rari - Valentina Nardi, MD
Inflammatio metastatica Myofibroblastic Tumor - Alanna Church, MD et Katherina Janeway, MD, MMSc
Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Ecclesia, Janeway et Sullivan
C. Interpretatio Sequentiae et Exemplar Number Variantes (Cancer NGS) - Fei Dong, MD
Orci Interpretatio pro Gene Fusiones - Valentina Nardi, MD
C. Interpretatio Germline Cancri Predisposition - Diana Mandelker, MD, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Dong, Mandelker et Nardi
Vivere Provectus Workshop: posuere eget Interpretatio - Adam Fisch, MD, PhD
Topica in Myeloid Neoplasmata - Valentina Nardi, MD
Topics in Measurable (minimal) Residua Morbus Testis - Annette S. Kim, MD, PhD
Targetable Fusiones in Acuti Lymphoblastic Leukemia - Marian H. Harris, MD, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Harris, Nardi et Kim
Diagnostica hypothetica pro B-cella Lymphomas - Scott B. Lovitch, MD, PhD
Diagnostica hypothetica pro T-cell Lymphomas - David Weinstock, MD
Hematological Malignancy Case Presentation - Hanno Hock, MD, PhD et Valentina Nardi, MD
Et respondendum est, quod Quaeritur Sessio - Moderator - Lynette M. Sholl, MD; Drs. Lovitch, Nardi, Weinstock et Hock
Diagnostics hypotheticae pro Sarcomas - Adrian Marino-Enriquez, MD, PhD
Diagnostica hypothetica pro Gliomas - David Meredith, MD, PhD
Cusci Applications totius Genome DNA Methylation Profiling - Matija Snuderl, MD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Marino-Enriquez, Meredith et Snuderl
Provectus Workshop: Exemplar Number per Microarray & NGS - Adrianus Dubuc
Diagnostics hypotheticae pro pulmonis Cancro - Lynette Sholl M., MD
Diagnostica hypothetica pro thyroideo Cancri - Dora Dias-Santagata, PhD, FACMG
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Dias-Santagata et Sholl
Biomarkers hypothetica pro GU Canceribus - Atish Choudhury, MD, Ph.D.
Diagnostics hypotheticae pro GI Canceribus - Jonathan Nowak, MD, PhD
Cusci Casus Praesentationis ac Discussion (Lung Tumor) - Mark M. Awad, MD, PhD et Lynette M. Sholl, MD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Awad, Sholl, Choudhury et Nowak
Exosculatio et regulatory Exitus - Jochen K. Lennerz, MD, PhD
Opportunitates in Lab Management Molecular - Neal Lindeman, MD
Fusce iudiciis et regulatory Negotiis - Marmor Hetal, PhD
Et respondendum est, quod Quaeritur Sessio - Moderator - Valentina Nardi, MD; Drs. Iafrate, Lennerz, Lindeman et Marble
De Release Date: October 30, 2021
Cessatio Date: January 31, 2024